ArticleAJNR. American journal of neuroradiology2015
Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation.
Article in AJNR. American journal of neuroradiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 50 citations in OpenAlex.
- Prognostic value of Amyloid PET in Real-World Amnestic MCI: Influence of reader experience and interpretation method.European journal of nuclear medicine and molecular imaging · 2026Article
- Consistency Analysis of Centiloid Values Across Three Commercial Software Platforms for Amyloid PET Quantification.Diagnostics (Basel, Switzerland) · 2025Article
- Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Review
- Interrater agreement and variability in visual reading of [18F] flutemetamol PET images.Annals of nuclear medicine · 2025Article
- Impact of shortening time on diagnosis ofEJNMMI research · 2024Article
- Novel β-amyloid PET Imaging Study of [ACS omega · 2024Article
- Improving diagnostic precision in amyloid brain PET imaging through data-driven motion correction.EJNMMI physics · 2024Article
- Comparison of consistency in centiloid scale among different analytical methods in amyloid PET: the CapAIBL, VIZCalc, and Amyquant methods.Annals of nuclear medicine · 2024Article
- AmyloidPETNet: Classification of Amyloid Positivity in Brain PET Imaging Using End-to-End Deep Learning.Radiology · 2024Article
- Clinical Performance Evaluation of an Artificial Intelligence-Powered Amyloid Brain PET Quantification Method.Nuclear medicine and molecular imaging · 2024Article
- Development of software for measuring brain amyloid accumulation usingBrain and behavior · 2023Article
- PET molecular imaging for pathophysiological visualization in Alzheimer's disease.European journal of nuclear medicine and molecular imaging · 2023Review
- Clinical impact of amyloid PET usingAnnals of nuclear medicine · 2022Article
- A comparison of advanced semi-quantitative amyloid PET analysis methods.European journal of nuclear medicine and molecular imaging · 2022Article
- Decreased imaging time of amyloid PET using [Radiological physics and technology · 2022Article
- A 4-Year Follow-Up of Subjects with Visually Equivocal Amyloid Positron Emission Tomography Findings from the Alzheimer's Disease Neuroimaging Initiative Cohort.Nuclear medicine and molecular imaging · 2021Article
- Visual interpretation of [European journal of nuclear medicine and molecular imaging · 2021Article
- Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load.Neurology · 2020Article
- Validation of a spatial normalization method using a principal component derived adaptive template for [American journal of nuclear medicine and molecular imaging · 2020Article
- Spill-in counts in the quantification ofEJNMMI physics · 2019Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
background and purposeFluorine-18 florbetapir is a recently developed β-amyloid plaque positron-emission tomography imaging agent with high sensitivity, specificity, and accuracy in the detection of moderate-to-frequent cerebral cortical β-amyloid plaque. However, the FDA has expressed concerns about the consistency of interpretation of [(18)F] florbetapir PET brain scans. We hypothesized that incorporating automated cerebral-to-whole-cerebellar standardized uptake value ratios into [(18)F] florbetapir PET brain scan interpretation would reduce this interreader variability. MATERIALS AND
methodsThis randomized, blinded-reader study used previously acquired [(18)F] florbetapir scans from 30 anonymized patients who were enrolled in the Alzheimer's Disease Neuroimaging Initiative 2. In 4 separate, blinded-reading sessions, 5 readers classified 30 cases as positive or negative for significant β-amyloid deposition either qualitatively alone or qualitatively with additional adjunct software that determined standardized uptake value ratios. A κ coefficient was used to calculate interreader agreement with and without the use of standardized uptake value ratios.
resultsThere was complete interreader agreement on 20/30 cases of [(18)F] florbetapir PET brain scans by using qualitative interpretation and on 27/30 scans interpreted with the adjunct use of standardized uptake value ratios. The κ coefficient for the studies read with standardized uptake value ratios (0.92) was significantly higher compared with the qualitatively read studies (0.69, P = .006).
conclusionsUse of standardized uptake value ratios improves interreader agreement in the interpretation of [(18)F] florbetapir images.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.